HALO

Halozyme Therapeutics, Inc.

Company with tickers: HALO

CIK

1159036

CUSIP

40637H109

Shares Outstanding

118,613,000

Website

https://www.halozyme.com

Investor Relations

https://ir.halozyme.com/overview/default.aspx

13F Activity (30d)

31 filings 10 filers

Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.

Recent news

Date	Headline
2026-06-15	Halozyme Confirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Newly Released Draft Medicare Drug Price Negotiation Program Proposed Rule for IPAY 2029
2026-05-11	HALOZYME REPORTS FIRST QUARTER 2026 RESULTS AND REITERATES 2026 FINANCIAL GUIDANCE
2026-05-07	Halozyme Announces Global Collaboration and License Agreement with GSK to Develop Subcutaneous Formulations of Multiple Promising Oncology Targets
2026-05-06	Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™ Technology
2026-04-30	Halozyme to Report First Quarter 2026 Financial and Operating Results
2026-04-30	Halozyme Appoints Darren Snellgrove as Chief Financial Officer
2026-04-07	Halozyme Announces Global Collaboration and License Agreement with Vertex Pharmaceuticals for Hypercon™ Technology
2026-03-12	Halozyme Appoints David Ramsay as Interim Chief Financial Officer
2026-03-06	U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma
2026-02-25	Halozyme to Participate in Upcoming Investor Conferences

Past events

Date	Event	Type
2026-05-11	Halozyme 1Q 2026 Financial and Operating Results	Event
2026-03-11	The Citizens Life Sciences Conference	Conference
2026-03-10	Leerink Partners Global Healthcare Conference	Conference
2026-03-03	TD Cowen 46th Annual Healthcare Conference	Conference
2026-02-17	Halozyme 4Q and FY 2025 Financial and Operating Results Conference Call	Conference
2026-01-28	Investor Conference Call	Conference
2025-12-02	8th Annual Evercore Healthcare Conference	Conference
2025-11-03	Halozyme To Host Third Quarter 2025 Financial and Operating Results Conference Call	Conference
2025-10-01	Halozyme Investor Call	Event
2025-09-08	Morgan Stanley 23rd Annual Global Healthcare Conference	Conference
2025-09-04	2025 Wells Fargo Healthcare Conference	Conference
2025-08-05	Halozyme To Host Second Quarter 2025 Financial and Operating Results Conference Call	Conference
2025-06-09	Goldman Sachs 46th Annual Global Healthcare Conference	Conference
2025-05-13	BofA Securities 2025 Healthcare Conference	Conference
2025-05-06	Halozyme To Host First Quarter 2025 Financial and Operating Results Conference Call	Conference
2025-03-05	TD Cowen 45th Annual Healthcare Conference	Conference
2025-02-18	Halozyme to Host 4Q and FY 2024 Financial and Operating Results Conference Call	Conference
2025-01-08	Halozyme Investor Conference Call	Conference
2024-12-04	Piper Sandler 36th Annual Healthcare Conference	Conference
2024-12-04	7th Annual Evercore ISI HealthCONx Conference	Conference
2024-10-31	Halozyme To Host Third Quarter 2024 Financial and Operating Results Conference Call	Conference
2024-10-24	Halozyme Investor Update	Event
2024-09-10	H.C. Wainwright 26th Annual Global Investment Conference	Conference
2024-09-04	2024 Wells Fargo Healthcare Conference	Conference
2024-08-06	Halozyme To Host Second Quarter 2024 Financial and Operating Results Conference Call	Conference

Source: https://ir.halozyme.com/overview/default.aspx